Gain Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability.

CEO

Gene C. Mack

CEOGene C. Mack

Employees

Employees25

Headquarters

Bethesda, Maryland

HeadquartersBethesda, Maryland

Founded

2017

Founded2017

Employees

Employees25

GANX Key Statistics

Market cap

54.68M

Market cap54.68M

Price-Earnings ratio

-2.15

Price-Earnings ratio-2.15

Dividend yield

—

Dividend yield—

Average volume

253.51K

Average volume253.51K

High today

$2.04

High today$2.04

Low today

$1.85

Low today$1.85

Open price

$1.88

Open price$1.88

Volume

12.36K

Volume12.36K

52 Week high

$3.19

52 Week high$3.19

52 Week low

$0.89

52 Week low$0.89

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own GANX. This list is generated using Robinhood data, and it’s not a recommendation.